{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:19:03Z","timestamp":1788481143797,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>\n                    Aldose reductase (AR) is an important target in the development of therapeutics against hyper-glycemia-induced health complications such as retinopathy, etc. In this study, we employed a combination of structure-based drug design, molecular simulation, and free energy calculation approaches to identify potential hit molecules against anti-diabetic (anti-hyperglycemic)-induced health complications. The 3D structure of aldoreductase was screened for multiple compound libraries (1,00,000 compounds) and identified as ZINC35671852, ZINC78774792 from the ZINC database, Diamino-di nitro-methyl dioctyl phthalate, and Penta-o-galloyl-glucose from the South African natural compounds database, and Bisindolylmethane thiosemi-carbazides and Bisindolylme-thane-hydrazone from the Inhouse database for this study. The mode of binding interactions of the selected compounds later predicted their aldose reductase inhibitory potential. These com-pounds interact with the key active site residues through hydrogen bonds, salt bridges, and \u03c0-\u03c0 interactions. The structural dynamics and binding free energy results further revealed that these compounds possess stable dynamics with excellent binding free energy scores. The structures of the lead inhibitors can serve as templates for developing novel inhibitors, and\n                    <jats:italic>in vitro<\/jats:italic>\n                    testing to confirm their anti-diabetic potential is warranted. The current study is the first to design small molecule inhibitors for the aldoreductase protein that can be used in the development of therapeutic agents to treat diabetes.\n                  <\/jats:p>","DOI":"10.3389\/fmolb.2023.1271569","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:22:18Z","timestamp":1700439738000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploring potent aldose reductase inhibitors for anti-diabetic (anti-hyperglycemic) therapy: integrating structure-based drug design, and MMGBSA approaches"],"prefix":"10.3389","volume":"10","author":[{"given":"Muhammad","family":"Shahab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad M.","family":"Alshabrmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bourhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezahign Fentahun","family":"Wondmie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Mohammad Salamatullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2183031","article-title":"Identification of potential biological target for trypanocidal sesquiterpene lactones derivatives","author":"Adessi","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B2","doi-asserted-by":"publisher","first-page":"104612","DOI":"10.1016\/j.arabjc.2023.104612","article-title":"Design, synthesis, docking and mechanistic studies of new thiazolyl\/thiazolidinylpyrimidine-2, 4-dione antiproliferative agents","volume":"16","author":"Aly","year":"2023","journal-title":"Arabian J. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/biom12040485","article-title":"In search of differential inhibitors of aldose reductase","volume":"12","author":"Balestri","year":"2022","journal-title":"Biomolecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0885-4505(92)90055-4","article-title":"Aldose reductase: congenial and injurious profiles of an enigmatic enzyme","volume":"48","author":"Bhatnagar","year":"1992","journal-title":"Biochem. Med. metabolic Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1073\/pnas.0711659105","article-title":"Quantum model of catalysis based on a mobile proton revealed by subatomic x-ray and neutron diffraction studies of h-aldose reductase","volume":"105","author":"Blakeley","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.1016\/s0021-9258(18)60566-6","article-title":"The aldo-keto reductase superfamily: cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases","volume":"264","author":"Bohren","year":"1989","journal-title":"J. Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1093\/nar\/gkz499","article-title":"Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations","volume":"47","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1021\/acs.jcim.2c00961","article-title":"Decoding the identification mechanism of an SAM-III Riboswitch on ligands through multiple independent Gaussian-accelerated molecular dynamics simulations","volume":"62","author":"Chen","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"B10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/antiox11040784","article-title":"Role of oxidative stress in diabetic cardiomyopathy","volume":"11","author":"De Geest","year":"2022","journal-title":"Antioxidants"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2000118","DOI":"10.1002\/ardp.202000118","article-title":"Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and \u03b1-glycosidase and molecular docking studies","volume":"353","author":"Demir","year":"2020","journal-title":"Arch. Pharm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1021\/acs.jcim.2c01504","article-title":"Vina-GPU 2.0: further accelerating AutoDock Vina and its derivatives with graphics processing units","volume":"63","author":"Ding","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2167114","article-title":"Network pharmacology-and molecular simulation-based exploration of therapeutic targets and mechanisms of heparin for the treatment of sepsis\/COVID-19","author":"Fang","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/978-3-031-25519-9_49","article-title":"Biochemical mechanisms of vascular complications in diabetes","volume-title":"The diabetes textbook: clinical principles, patient management and public health issues","author":"Flores","year":"2023"},{"key":"B15","doi-asserted-by":"publisher","first-page":"106326","DOI":"10.1016\/j.phrs.2022.106326","article-title":"Polyol pathway and redox balance in diabetes","volume":"182","author":"Garg","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1080\/07391102.2022.2128878","article-title":"New lead compounds identification against KRas mediated cancers through pharmacophore-based virtual screening and in vitro assays","volume":"41","author":"Ghufran","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jsb.2006.06.010","article-title":"Visualizing density maps with UCSF Chimera","volume":"157","author":"Goddard","year":"2007","journal-title":"J. Struct. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"106442","DOI":"10.1016\/j.compbiomed.2022.106442","article-title":"Discovery of allosteric SHP2 inhibitors through ensemble-based consensus molecular docking, endpoint and absolute binding free energy calculations","volume":"152","author":"Jama","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00041552-200203000-00014","article-title":"Hypertension and diabetes","volume":"11","author":"Jandeleit-Dahm","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/bj3260625","article-title":"Comparative anatomy of the aldo\u2013keto reductase superfamily","volume":"326","author":"Jez","year":"1997","journal-title":"Biochem. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/jpm12020271","article-title":"Clinical observation of SGLT2 inhibitor therapy for cardiac arrhythmia and related cardiovascular disease in diabetic patients with controlled hypertension","volume":"12","author":"Jhuo","year":"2022","journal-title":"J. Personalized Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fchem.2018.00023","article-title":"Structure based virtual screening studies to identify novel potential compounds for GPR142 and their relative dynamic analysis for study of type 2 diabetes","volume":"6","author":"Kaushik","year":"2018","journal-title":"Front. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"106797","DOI":"10.1016\/j.compbiomed.2023.106797","article-title":"Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations","volume":"158","author":"Khan","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1080\/07391102.2020.1779128","article-title":"Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)","volume":"39","author":"Khan","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0014-4835(90)90096-d","article-title":"A thirty year journey in the polyol pathway","volume":"50","author":"Kinoshita","year":"1990","journal-title":"Exp. eye Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1021\/bi036046x","article-title":"Crystal structure of human prostaglandin F synthase (AKR1C3)","volume":"43","author":"Komoto","year":"2004","journal-title":"Biochemistry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2796.1994.tb00799.x","article-title":"Myocardial infarct size and mortality in patients with non\u2010insulin\u2010dependent diabetes mellitus","volume":"236","author":"Lehto","year":"1994","journal-title":"J. Intern. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1023\/a:1015328625394","article-title":"Metabolic abnormalities in the diabetic heart","volume":"7","author":"Lopaschuk","year":"2002","journal-title":"Heart Fail. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1021\/acs.jchemed.2c00779","article-title":"Using PyMOL to understand why COVID-19 vaccines save lives","volume":"100","author":"Maya D\u00edaz","year":"2023","journal-title":"J. Chem. Educ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.3390\/molecules28114389","article-title":"Ligand-based virtual screening, molecular docking, and molecular dynamic simulations of new \u03b2-estrogen receptor activators with potential for pharmacological obesity treatment","volume":"28","author":"M\u00e9ndez-\u00c1lvarez","year":"2023","journal-title":"Molecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107613","DOI":"10.1016\/j.jdiacomp.2020.107613","article-title":"Molecular complexities underlying the vascular complications of diabetes mellitus\u2013A comprehensive review","volume":"34","author":"Paul","year":"2020","journal-title":"J. Diabetes its Complicat."},{"key":"B32","first-page":"116","article-title":"Insight into polyol pathway for diabetic wound care supported by applications of scaffolds","volume":"30","author":"Ramachandran","year":"2023","journal-title":"Romanian J. Diabetes Nutr. Metabolic Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"33019","DOI":"10.1074\/jbc.M603819200","article-title":"Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264. 7 murine macrophages","volume":"281","author":"Ramana","year":"","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cyto.2006.11.003","article-title":"Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages","volume":"36","author":"Ramana","year":"2006","journal-title":"Cytokine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.106.630830","article-title":"Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition","volume":"114","author":"Ramana","year":"","journal-title":"Circulation"},{"key":"B36","volume-title":"Protein preparation wizard","author":"Schr\u00f6dinger","year":"2011"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101281","DOI":"10.1016\/j.imu.2023.101281","article-title":"Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site","volume":"40","author":"Shahab","year":"","journal-title":"Inf. Med. Unlocked"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2216278","article-title":"Machine learning-based drug design for identification of thymidylate kinase inhibitors as a potential anti-Mycobacterium tuberculosis","author":"Shahab","year":"","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.hyp.37.4.1053","article-title":"Diabetes, hypertension, and cardiovascular disease: an update","volume":"37","author":"Sower","year":"2001","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1210\/er.2004-0028","article-title":"Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options","volume":"26","author":"Srivastava","year":"2005","journal-title":"Endocr. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/0735-1097(94)00367-y","article-title":"Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail","volume":"25","author":"Stone","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8899240","DOI":"10.1155\/2023\/8899240","article-title":"Flavonoids as strong inhibitors of MAPK3: a computational drug discovery approach","volume":"2023","author":"Taherkhani","year":"2023","journal-title":"Int. J. Anal. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ijbiomac.2018.08.004","article-title":"Diarylmethanon, bromophenol and diarylmethane compounds: discovery of potent aldose reductase, \u03b1-amylase and \u03b1-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia","volume":"119","author":"Taslimi","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/bioinformatics\/bty816","article-title":"Large-scale prediction of binding affinity in protein\u2013small ligand complexes: the PRODIGY-LIG web server","volume":"35","author":"Vangone","year":"2019","journal-title":"Bioinformatics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/187152512802651097","article-title":"Aldose reductase, oxidative stress and diabetic cardiovascular complications","volume":"10","author":"Vedantham","year":"2012","journal-title":"Cardiovasc. Hematological Agents Med. Chem. Former. Curr. Med. Chemistry-Cardiovascular Hematological Agents)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.3390\/molecules28124773","article-title":"Identification mechanism of BACE1 on inhibitors probed by using multiple separate molecular dynamics simulations and comparative calculations of binding free energies","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"B48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.febslet.2011.11.023","article-title":"The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase","volume":"586","author":"Zheng","year":"2012","journal-title":"FEBS Lett."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1271569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:22:21Z","timestamp":1700439741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1271569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":48,"alternative-id":["10.3389\/fmolb.2023.1271569"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1271569","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"article-number":"1271569"}}